Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

JOURNEY II XR Safety and Effectiveness PMCF

← catalyst calendar

NCT03136887 · readout ≤ 985 d

Sponsored by Smith & Nephew, Inc. (industry) · SNN — their whole pipeline →.

Phase
Status
Active, not recruiting
Study type
Observational
Enrollment
176actual
Sites
14
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2017-07-28actualWhen the study began enrolling
Primary completionApr 2029estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionApr 2029estimatedThe whole study's end, after follow-up
First posted2017-05-02actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2024-08-12actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee
  • Unilateral Post-Traumatic Osteoarthritis of Knee
  • Knee Osteoarthritis
  • Degenerative Arthritis Peripheral Joint
  • Failed Osteotomies
  • Failed Unicompartmental Replacement

Intervention

  • Device: JOURNEY II XR Total Knee System

Primary outcome

what the primary-completion date above is the date OF
Implant survival rate
measured 10 years

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · SNN's whole pipeline · Catalyst calendar · Every registered study · What changed